Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 2,476-2,500 of 3,186
CompletedNCT03260257

A Neurofeedback Intervention to Improve Working Memory in Schizophrenia

This study exists to understand how brain scans or other body measurements holds up over time after the earliest research stage. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
TerminatedNCT03896945

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

This study exists to compare options and see whether the medication AVP-786 offers something meaningfully different. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Bulgaria, Poland, United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
TerminatedNCT02261519

Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
CompletedNCT05053451

Brain Stimulation, Clinical Symptoms and Cognition

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Schizophrenia
TerminatedNCT01908192

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

This study exists to explore whether symptom tracking and monitoring could improve care and understanding. Researchers are trying to understand whether symptom tracking and monitoring can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 12 Years to 17 Years
Countries
Taiwan, United States
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
CompletedNCT03323437

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Schizophrenia
CompletedNCT02129348

Treatment of Psychosis and Agitation in Alzheimer's Disease

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOther
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
CompletedNCT04248517

Using mHealth to Optimize Pharmacotherapy Regimens

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
RecruitingNCT05823532

Anti-Inflammatory Challenge in Schizophrenia

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
CompletedNCT03822910

Hippocampal Memory Circuits in Delusions

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
China, United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
CompletedNCT01425671

Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 14 Years to 62 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT01892384

Safety and Tolerability of BI 409306 in Patients With Schizophrenia

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
TerminatedNCT05319080

Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 22 Years to 55 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
CompletedNCT02392468

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

This study exists to better understand the safety of the medication Systemic and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Systemic in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT04532034

Facilitating Engagement in Evidence-Based Treatment for Early Psychosis

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
Temple University
Condition
Schizophrenia
CompletedNCT02155699

Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 24 Years
Countries
United States
Sponsor
University of Colorado, Boulder
Condition
Schizophrenia
CompletedNCT03983421

Feasibility of an Early Detection Program for Early Psychosis on a College Campus

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 15 Years to 30 Years
Countries
United States
Sponsor
University of New Mexico
Condition
Schizophrenia
CompletedNCT03648268

Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia
CompletedNCT03955250

Mobile After-Care Support App: Pilot RCT

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Schizophrenia
CompletedNCT03382639

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Bulgaria, Czech Republic, Germany, Italy, Poland, Spain, Ukraine, United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia